The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quéméneur, L.
Right arrow Articles by Genestier, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quéméneur, L.
Right arrow Articles by Genestier, L.
The Journal of Immunology, 2003, 170: 4986-4995.
Copyright © 2003 by The American Association of Immunologists

Differential Control of Cell Cycle, Proliferation, and Survival of Primary T Lymphocytes by Purine and Pyrimidine Nucleotides1

Laurence Quéméneur*, Luc-Marie Gerland{dagger}, Monique Flacher*, Martine Ffrench{dagger}, Jean-Pierre Revillard* and Laurent Genestier2,*

* Laboratoire d’immunopharmacologie, Institut National de la Santé et de la Recherche Médicale Unité 503, Centre d’Etudes et de Recherche en Virologie et Immunologie, Institut Fédératif de Recherche 128 Biosciences Lyon-Gerland, and {dagger} Laboratoire d’Hématologie-Cytogénétique, Institut National de la Santé et de la Recherche Médicale Unité 453, Hopital E. Herriot, Lyon, France

Purine and pyrimidine nucleotides play critical roles in DNA and RNA synthesis as well as in membrane lipid biosynthesis and protein glycosylation. They are necessary for the development and survival of mature T lymphocytes. Activation of T lymphocytes is associated with an increase of purine and pyrimidine pools. However, the question of how purine vs pyrimidine nucleotides regulate proliferation, cell cycle, and survival of primary T lymphocytes following activation has not yet been specifically addressed. This was investigated in the present study by using well-known purine (mycophenolic acid, 6-mercaptopurine) and pyrimidine (methotrexate, 5-fluorouracil) inhibitors, which are used in neoplastic diseases or as immunosuppressive agents. The effect of these inhibitors was analyzed according to their time of addition with respect to the initiation of mitogenic activation. We showed that synthesis of both purine and pyrimidine nucleotides is required for T cell proliferation. However, purine and pyrimidine nucleotides differentially regulate the cell cycle since purines control both G1 to S phase transition and progression through the S phase, whereas pyrimidines only control progression from early to intermediate S phase. Furthermore, inhibition of pyrimidine synthesis induces apoptosis whatever the time of inhibitor addition whereas inhibition of purine nucleotides induces apoptosis only when applied to already cycling T cells, suggesting that both purine and pyrimidine nucleotides are required for survival of cells committed into S phase. These findings reveal a hitherto unknown role of purine and pyrimidine de novo synthesis in regulating cell cycle progression and maintaining survival of activated T lymphocytes.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
X.-X. Sun, M.-S. Dai, and H. Lu
Mycophenolic Acid Activation of p53 Requires Ribosomal Proteins L5 and L11
J. Biol. Chem., May 2, 2008; 283(18): 12387 - 12392.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. A. M. Wessels, T. W. J. Huizinga, and H.-J. Guchelaar
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis
Rheumatology, March 1, 2008; 47(3): 249 - 255.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
A. Gaffo, K. G. Saag, and J. R. Curtis
Treatment of rheumatoid arthritis
Am. J. Health Syst. Pharm., December 15, 2006; 63(24): 2451 - 2465.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Poppe, I. Tiede, G. Fritz, C. Becker, B. Bartsch, S. Wirtz, D. Strand, S. Tanaka, P. R. Galle, X. R. Bustelo, et al.
Azathioprine Suppresses Ezrin-Radixin-Moesin-Dependent T Cell-APC Conjugation through Inhibition of Vav Guanosine Exchange Activity on Rac Proteins
J. Immunol., January 1, 2006; 176(1): 640 - 651.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
B. N. Cronstein
Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis
Pharmacol. Rev., June 1, 2005; 57(2): 163 - 172.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. Tartakover Matalon, A. Ornoy, A. Fishman, L. Drucker, and M. Lishner
The effect of 6-mercaptopurine on early human placental explants
Hum. Reprod., May 1, 2005; 20(5): 1390 - 1397.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. W. Thomas, G. M. Myhre, R. Tschumper, R. Sreekumar, D. Jelinek, D. J. McKean, J. J. Lipsky, W. J. Sandborn, and L. J. Egan
Selective Inhibition of Inflammatory Gene Expression in Activated T Lymphocytes: A Mechanism of Immune Suppression by Thiopurines
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 537 - 545.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Quemeneur, L. Beloeil, M.-C. Michallet, G. Angelov, M. Tomkowiak, J.-P. Revillard, and J. Marvel
Restriction of De Novo Nucleotide Biosynthesis Interferes with Clonal Expansion and Differentiation into Effector and Memory CD8 T Cells
J. Immunol., October 15, 2004; 173(8): 4945 - 4952.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.